News Releases | Lucira Health, Inc

Year

12 May '22

Lucira Health Announces First Quarter 2022 Results and Business Update

EMERYVILLE, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) (“Lucira Health,” “Lucira” or the “Company”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease tests, today reported financial

12 May '22

Lucira Files for Authorization of First-of-its-Kind COVID-19 & Flu At-Home Molecular Test

This first ever at-home COVID-19 and flu test is designed to allow individuals to differentiate between the infections and seek appropriate treatment within 30 minutes from home EMERYVILLE, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a

09 May '22

Lucira Receives CE Mark for both COVID-19 & Flu and COVID-19 Molecular Tests

EMERYVILLE, Calif., May 09, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of innovative infectious disease tests, announced that both its COVID-19 & Flu and COVID-19 molecular

04 May '22

Lucira Health to Participate in Bank of America 2022 Healthcare Conference

EMERYVILLE, Calif., May 04, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that the company will participate in

28 Apr '22

Lucira Health to Announce First Quarter 2022 Financial Results

EMERYVILLE, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that the company will report first

21 Apr '22

Lucira Health and USA Boxing Announce Exclusive Partnership for the 2022 Season

Lucira is the official COVID-19 test provider of USA Boxing athletes and staff and will commit $5 of support to the organization for each test purchased by fans Emeryville, Calif., April 21, 2022 -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technology company

11 Apr '22

Lucira Health Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

EMERYVILLE, Calif., April 11, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that on April 6, 2022, the Board of Directors of

31 Mar '22

Lucira Donates Rapid Molecular At-Home COVID-19 Test Kits to Protect the Safety of Tonga Red Cross Society Workers

COVID-19 Comes to Isolated Pacific Island of Tonga And Cases Soar After Volcanic Eruption and Tsunami EMERYVILLE, Calif., (March 31, 2022) -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of

29 Mar '22

Lucira Health's COVID-19 & Flu At-Home Molecular Test Shows Positive Clinical Study Results

COVID-19 and Influenza (flu) have similar symptoms, as well as effective but distinct treatments, making tests to differentiate between these infections crucial The Lucira COVID-19 & Flu test is a single at-home molecular test designed to independently diagnose COVID-19, Flu A and Flu B in less

24 Mar '22

Lucira Health’s PCR-Quality At-Home COVID-19 Test Now Available Direct to Consumers in Canada

Lucira’s molecular test provides PCR-quality results in 30 minutes in a simple single-use test Lucira was the first at-home COVID-19 test authorized in Canada and has been used in public health programs and for safe travel EMERYVILLE, CA, March 24, 2022 (GLOBE NEWSWIRE) — Lucira Health, Inc.

Pagination

Current page 1
Page 2
Next page
Last page

Displaying 1 - 10 of 16